HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints/Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Pearce, D. J. Articles by Bonnet, D. Search for Related Content PubMed PubMed Citation Articles by Pearce, D. J. Articles by Bonnet, D.

Characterization of Cells with a High Aldehyde Dehydrogenase Activity from Cord Blood and Acute Myeloid Leukemia Samples

^a Hematopoietic Stem Cell Laboratory,
^b FACS Laboratory, London Research Institute, Cancer Research UK, London, United Kingdom;
^c Cancer Research UK Department of Medical Oncology, St. Bartholomew’s Hospital, West Smithfield, London, United Kingdom

Key Words. Human CD34⁺ cells • Acute myelogenous leukemia • Selection technologies • NOD/SCID model

Correspondence: Dominique Bonnet, Ph.D., Hematopoietic Stem Cell Laboratory, Cancer Research UK, London Research Institute, 44 Lincoln’s Inn Fields, London WC2A 3PX, United Kingdom. Telephone: 020-726-93281; Fax: 020-726-93581; e-mail: dominique.bonnet{at}cancer.org.uk

Aldehyde dehydrogenase (ALDH) is a cytosolic enzyme that is responsible for the oxidation of intracellular aldehydes. Elevated levels of ALDH have been demonstrated in murine and human progenitor cells compared with other hematopoietic cells, and this is thought to be important in chemoresistance. A method for the assessment of ALDH activity in viable cells recently has been developed and made commercially available in a kit format. In this study, we confirmed the use of the ALDH substrate kit to identify cord blood stem/progenitor cells. Via multicolor flow cytometry of cord blood ALDH⁺ cells, we have expanded on their phenotypic analysis. We then assessed the incidence, morphology, phenotype, and nonobese diabetic/ severe combined immunodeficiency engraftment ability of ALDH⁺ cells from acute myeloid leukemia (AML) samples. AML samples had no ALDH⁺ cells at all, an extremely rare nonmalignant stem/progenitor cell population, or a less rare, leukemic stem cell population. Hence, in addition to identifying nonmalignant stem cells within some AML samples, a high ALDH activity also identifies some patients’ CD34⁺/ CD38^– leukemic stem cells. The incidence of normal or leukemic stem cells with an extremely high ALDH activity may have important implications for resistance to chemotherapy. Identification and isolation of leukemic cells on the basis of ALDH activity provides a tool for their isolation and further analysis.

This article has been cited by other articles:

				B. P. Levi, O. H. Yilmaz, G. Duester, and S. J. Morrison Aldehyde dehydrogenase 1a1 is dispensable for stem cell function in the mouse hematopoietic and nervous systems Blood, February 19, 2009; 113(8): 1670 - 1680. [Abstract] [Full Text] [PDF]

				G. Feldmann, V. Fendrich, K. McGovern, D. Bedja, S. Bisht, H. Alvarez, J.-B. M. Koorstra, N. Habbe, C. Karikari, M. Mullendore, et al. An orally bioavailable small-molecule inhibitor of Hedgehog signaling inhibits tumor initiation and metastasis in pancreatic cancer Mol. Cancer Ther., September 1, 2008; 7(9): 2725 - 2735. [Abstract] [Full Text] [PDF]

				S. Ma, K. W. Chan, T. K.-W. Lee, K. H. Tang, J. Y.-H. Wo, B.-J. Zheng, and X.-Y. Guan Aldehyde Dehydrogenase Discriminates the CD133 Liver Cancer Stem Cell Populations Mol. Cancer Res., July 1, 2008; 6(7): 1146 - 1153. [Abstract] [Full Text] [PDF]

				C. E. Eyler and J. N. Rich Survival of the Fittest: Cancer Stem Cells in Therapeutic Resistance and Angiogenesis J. Clin. Oncol., June 10, 2008; 26(17): 2839 - 2845. [Abstract] [Full Text] [PDF]

				T. J. Povsic, K. L. Zavodni, F. L. Kelly, S. Zhu, P. J. Goldschmidt-Clermont, C. Dong, and E. D. Peterson Circulating Progenitor Cells Can Be Reliably Identified on the Basis of Aldehyde Dehydrogenase Activity J. Am. Coll. Cardiol., December 4, 2007; 50(23): 2243 - 2248. [Abstract] [Full Text] [PDF]

				P. Luo, A. Wang, K. J. Payne, H. Peng, J.-g. Wang, Y. K. Parrish, J. W. Rogerio, T. J. Triche, Q. He, and L. Wu Intrinsic Retinoic Acid Receptor {alpha}-Cyclin-Dependent Kinase-Activating Kinase Signaling Involves Coordination of the Restricted Proliferation and Granulocytic Differentiation of Human Hematopoietic Stem Cells Stem Cells, October 1, 2007; 25(10): 2628 - 2637. [Abstract] [Full Text] [PDF]

				G. Feldmann, S. Dhara, V. Fendrich, D. Bedja, R. Beaty, M. Mullendore, C. Karikari, H. Alvarez, C. Iacobuzio-Donahue, A. Jimeno, et al. Blockade of Hedgehog Signaling Inhibits Pancreatic Cancer Invasion and Metastases: A New Paradigm for Combination Therapy in Solid Cancers Cancer Res., March 1, 2007; 67(5): 2187 - 2196. [Abstract] [Full Text] [PDF]

				D. A. Hess, L. Wirthlin, T. P. Craft, P. E. Herrbrich, S. A. Hohm, R. Lahey, W. C. Eades, M. H. Creer, and J. A. Nolta Selection based on CD133 and high aldehyde dehydrogenase activity isolates long-term reconstituting human hematopoietic stem cells Blood, March 1, 2006; 107(5): 2162 - 2169. [Abstract] [Full Text] [PDF]